Suppr超能文献

机器人辅助肾移植:我们的首例病例。

Robotic-assisted kidney transplantation: our first case.

作者信息

Breda A, Gausa L, Territo A, López-Martínez J M, Rodríguez-Faba O, Caffaratti J, de León J Ponce, Guirado L, Villavicencio H

机构信息

Department of Urology, Fundaciò Puigvert, Autonoma University of Barcelona, Calle Cartagena 340-350, 08025, Barcelona, Spain.

Department of Urology, University of Modena and Reggio Emilia, Modena, Italy.

出版信息

World J Urol. 2016 Mar;34(3):443-7. doi: 10.1007/s00345-015-1673-6. Epub 2015 Aug 28.

Abstract

PURPOSE

Kidney transplantation is the preferred treatment for patients with end-stage renal disease. In order to reduce the morbidity of the open surgery, a robotic-assisted approach has been recently introduced. According to the published literature, the robotic surgery allows the performance of kidney transplantation under optimal operative conditions while maintaining the safety and the functional results of the open approach.

METHODS

We present the case of a mother donating to her daughter affected by end-stage renal disease (ESRD) due to Alport disease (creatinine: 353 umol/l; GFR: 13 ml/min per 1.73 m(2)).

RESULTS

A robotic-assisted kidney transplant (RAKT) was successfully performed. Surgical time was 120 min with 53 min for vascular suture. The estimated blood loss was <50 cc. The kidney started to produce urine intra-operatively with a rate of 250 cc/h, which remained constant over the next hours. During the first postoperative day, the patient was ambulating and started oral intake. Pain was minimal, and no analgesia was required after 48 h. Serum creatinine improved progressively to 89 umol/l on postoperative day 3. No surgical complications were recorded, and the patient was sent home on postoperative day 5.

CONCLUSION

We present the first Spanish transperitoneal pure RAKT from a living-related donor. We believe this is the second pure robotic-assisted kidney transplantation case performed in Europe. We believe that the potential advantages of RAKT are related to the quality of the vascular anastomosis, the possible lower complication rate and the shorter recovery of the recipients.

摘要

目的

肾移植是终末期肾病患者的首选治疗方法。为了降低开放手术的发病率,最近引入了机器人辅助方法。根据已发表的文献,机器人手术能够在最佳手术条件下进行肾移植,同时保持开放手术的安全性和功能效果。

方法

我们介绍了一位母亲为因奥尔波特综合征导致终末期肾病(肌酐:353μmol/l;肾小球滤过率:13ml/min/1.73m²)的女儿进行活体供肾移植的病例。

结果

成功实施了机器人辅助肾移植手术。手术时间为120分钟,血管缝合时间为53分钟。估计失血量<50cc。肾脏在术中开始产生尿液,速度为250cc/h,在接下来的几个小时内保持稳定。术后第一天,患者即可下床活动并开始经口进食。疼痛轻微,48小时后无需镇痛。术后第3天血清肌酐逐渐降至89μmol/l。未记录到手术并发症,患者于术后第5天出院。

结论

我们展示了首例来自活体亲属供体的西班牙经腹纯机器人辅助肾移植手术。我们认为这是欧洲第二例纯机器人辅助肾移植病例。我们相信机器人辅助肾移植的潜在优势与血管吻合质量、可能较低的并发症发生率以及受者较短的恢复时间有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验